Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Hepatology International
|
December 3, 2016
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Shi-Ming Lin, Sheng-Nan Lu, Ping-Tsung Chen, et al.
Journal of Clinical Gastroenterology
|
March 6, 2018
Water Exchange Produces Significantly Higher Adenoma Detection Rate Than Water Immersion: Pooled Data From 2 Multisite Randomized Controlled Trials
Felix W Leung, Malcolm Koo, Sergio Cadoni, et al.
British Journal of Cancer
|
January 20, 2022
Urine DNA biomarkers for hepatocellular carcinoma screening
Amy K Kim, James P Hamilton, Selena Y Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 17, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su, Tsung-Hui Hu, Chi-Yi Chen, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Hepatology International
|
December 3, 2016
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Shi-Ming Lin, Sheng-Nan Lu, Ping-Tsung Chen, et al.
Journal of Clinical Gastroenterology
|
March 6, 2018
Water Exchange Produces Significantly Higher Adenoma Detection Rate Than Water Immersion: Pooled Data From 2 Multisite Randomized Controlled Trials
Felix W Leung, Malcolm Koo, Sergio Cadoni, et al.
British Journal of Cancer
|
January 20, 2022
Urine DNA biomarkers for hepatocellular carcinoma screening
Amy K Kim, James P Hamilton, Selena Y Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 17, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su, Tsung-Hui Hu, Chi-Yi Chen, et al.
Page
of 8